Directory · US
Biotechnology in United States
A register of firms and the professionals working at them in the Biotechnology sector based in United States. Browse the public index, then filter or export on Kipplo.
Companies
2.7K on file
Scinomix
Scinomix is a leading provider of laboratory automation systems to customers in the Life Science Industry. Our standard line of robotic automation, consumables and custom automation capabilities can fulfill all of your laboratory automation needs. We are proud that our commitment to quality, reliability, and customer service brings us repeat customers and frequent referrals. In addition to offering our own fully automated systems, we also integrate many of our products with other manufacturers' instrumentation to provide complete solutions for our customers.
51 to 200 staff
Sling Health
Solving medical problems. Training innovators. Improving healthcare. Sling Health™ is a network of medical bioengineering, design, and entrepreneurship incubators at top universities around the country, founded in 2013 at Washington University in St. Louis. Today, the network has grown to include Harvard, MIT, U. Pennsylvania, U. Michigan, Tulane and Louisiana State U, Georgia Institute of Technology and Emory. This growth is happening in collaboration with the American Medical Association and many industry and academic sponsors. We form teams of medical, engineering, and business students with mentorship from faculty, healthcare professionals, and local entrepreneurs in order to tackle unmet needs in healthcare delivery and clinical medicine. Sling Health provides technical, clinical, business, and legal mentorship, initial funding and facilities for prototypes, and legal support necessary for teams to thrive as budding companies. As a student-led, volunteer based platform, we run at unparalleled cost. In 2014-15, we spent to support 133 students, yielding 12 companies that have collectively raised over $2.5 million since May 2015. Join us as we enable students to solve real world clinical problems!
11 to 50 staff
Sunflower Therapeutics
Sunflower Therapeutics is a unique biotechnology start-up focused on dramatically reducing the time and cost to develop and manufacture biologics for patients around the world. With a genetically-optimized host, data-driven process development, and a novel, ‘right-sized’ manufacturing unit, the experienced Sunflower team is creating an efficient, patient-centered, end-to-end drug production platform that we plan to deploy worldwide.
11 to 50 staff
Telesis Bio
Telesis Bio is empowering researchers to accelerate the creation of novel synthetic biology solutions to address some of humanity’s greatest challenges. With our breakthrough automation solutions for biological synthesis and expertise in DNA biology, we enable rapid, accurate, and reproducible writing of DNA and mRNA for wide-ranging biological applications. Around the world, innovators are leveraging Telesis Bio's technology to overcome current bottlenecks in synthetic biology workflows and advance the discovery of cutting-edge solutions for health and technology. We are proud of our growing collaborations with partners that include premier academic research institutions, emerging start-ups to nearly all of the Top 25 Biopharma companies. Telesis Bio is honored to play a part in several pioneering advances of our customers and collaborators ranging from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable cellular agricultural products.
51 to 200 staff
Trace Analytics, Llc
The experts on ISO 8573 compressed air testing. We test compressed air and gas quality for Pharmaceutical, Food and Medical Device Manufacturers per ISO 8573-1, ISO 8573-7, SQF Air Purity, Food Grade Air needs, BCAS & BRC recommendations or Custom Specifications. Breathing Air Quality for Fire (NFPA 1989), Diving & Industrial users, Medical Gases for Hospitals, Healthcare Facilities, and Veterinary Offices. Trace Analytics has been proudly serving customers worldwide since 1989. Contact us for your air quality testing needs! Manufacturing Compressed Air & Gas 1-800-247-1024 x 4 CDATest@AirCheckLab.com Breathing Air or Medical Gases 1-800-247-1024 x 3 ServiceTeam@AirCheckLab.com Quality Assurance is Proactive Quality Find Us on Facebook, Instagram, Pinterest, Twitter & YouTube!
11 to 50 staff
Tricontinent
TriContinent is a leading manufacturer of liquid handling solutions for Original Equipment Manufacturers (OEMs) in the medical, pharmaceutical, biotechnology, and laboratory industry. With its experienced Engineering, Technical, and Operations staff and capabilities, TriContinent designs and manufactures standard and customized syringe pumps, pipetting pumps, rotary valves, syringes, and liquid handling (XYZ) robots that meet the precise needs of its customers. Backed by over 45 years of engineering excellence and innovation and a global manufacturing network, TriContinent stands out as the reliable choice for OEMs worldwide. TriContinent Scientific is an Ingersoll Rand Business. Ingersoll Rand is a global market leader with a broad range of innovative and mission-critical air, fluid, energy, and medical technologies, providing services and solutions to increase industrial productivity and efficiency.
51 to 200 staff
Tune Therapeutics
The vast majority of human disease is governed by the epigenome, the subtle machinery that controls the volume of gene expression in cells. Tune Therapeutics is pioneering the creation of epi-therapeutic medicines with its powerful and precise epigenomic control platform, TEMPO. Unlike genome editing, TEMPO dials the volume of gene expression up or down towards healthy levels, without breaking or permanently rewriting DNA – and it can do this in multiple genes at once. This genetic tuning approach allows us to change cell fate and function at will, unlocking the ability to reverse pathways of cancer, genetic disease and aging. Our approach effectively expands the potential reach of genetic medicine – from targeting a limited range of rare conditions, to overcoming thousands of complex and chronic diseases that currently have no curative treatment.
51 to 200 staff
World Precision Instruments, Llc
For over 55 years, World Precision Instruments (WPI) has been a leading global manufacturer and provider of innovative research equipment and laboratory supplies to the life sciences, pharmaceutical, health care, and industrial markets. Our proven technology supports complex model development, including animal models and organ-on-a-chip systems, providing researchers with the tools to identify and validate drugs pre-clinically to understand mechanism of action, dosage, administration, drug-drug interactions, patient-specific reactions, pharmacokinetics, pharmacodynamics, safety and efficacy. Our areas of innovation focus on tissue and cell biology, fluidics, animal physiology and electrophysiology. With an extensive global network and a passion for innovation, WPI provides novel solutions to customer’s daily challenges. Browse our collection of premium lab equipment and supplies today to outfit your facility for success.
51 to 200 staff
Worthington Biochemical Corporation
Worthington is a privately owned, ISO9001 Certified. primary manufacturer of high-quality purified enzymes, proteins, nucleic acids and kits for biotech and life science research, diagnostic, biopharmaceutical and bioprocessing applications. Our reputation for producing quality products for all types of life science applications is the result of over 75 years of experience. Worthington’s in-house, full-service capabilities include initial extraction, fermentation, protein purification, lyophilization and packaging. All processes are fully documented and traceable from raw materials through final shipment. New Animal-Free enzymes and inhibitors are now available including Collagenases, DNases, RNases and other proteases for applications where minimization of potential animal-sourced pathogens is a required.
51 to 200 staff
Aligos Therapeutics
Aligos is a biopharmaceutical company developing targeted therapeutics to address unmet medical needs in liver and viral diseases including MASH, CHB and COVID-19.
51 to 200 staff
Alto Neuroscience
Alto Neuroscience is redefining psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective medicines, helping patients get better faster. Alto's Precision Psychiatry Platform™ measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most.
51 to 200 staff
Angiocrine Bioscience, Inc
Angiocrine Bioscience is a private, clinical stage engineered cell therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions. Our team is developing a pipeline of proprietary engineered endothelial cell (E-CEL® ) therapies for treating multiple life-threatening hemato-oncologic and immunologic conditions, as well as, regenerating tissues and organs that have been injured or damaged by diseases.
11 to 50 staff
Ariel Precision Medicine
Ariel delivers precision medicine solutions for the diagnosis, monitoring, and treatment of complex chronic diseases and disorders.
11 to 50 staff
Aro Biotherapeutics
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.
11 to 50 staff
Avalo Therapeutics
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation. Avalo’s lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. For more information about Avalo, please visit Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
11 to 50 staff
Aziyo Biologics, Inc
Aziyo Biologics is a fully integrated, commercially oriented regenerative medicine company. Since its founding in 2015 the Company has expanded through acquisitions and strategic partnerships, creating a high growth commercial entity. Its proprietary products are used in orthopedic, cardiovascular and other medical specialties.
51 to 200 staff
Bioworks
BioWorks provides integrated plant health management products and programs to customers in the horticulture and specialty agriculture markets. We want your crops, your business, and your people to thrive. Our biological control and plant nutrition products help accomplish this by eradicating harmful diseases and pests that threaten crops, while reducing reliance on harmful chemicals. We go above and beyond to protect your crops, strengthen them, and improve yield. BioWorks is a founding member of the Biological Products Industry Alliance (BPIA) and also a proud sponsor of the AFE scholarship program, funding the 'BioWorks IPM/Sustainable Practices Scholarship'. Please visit and find us on socials @bioworksipm
11 to 50 staff
Bolt Biotherapeutics, Inc
Bolt Biotherapeutics, Inc, based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients. Bolt’s technology is appropriate for a broad spectrum of antibodies targeting tumor antigens expressed on all types of cancer and therefore applicable to many types of patients, including those who are refractory to the current generation of checkpoint inhibitors. The company is led by a team with extensive oncology drug discovery and development experience. Bolt was founded by Dr. Ed Engleman, and its platform is based on technology exclusively licensed from Stanford University. The company is financed by world-class investors including Novo Holdings, Pivotal bioVenture Partners, Vivo Capital and Nan Fung Life Sciences. For more information about Bolt Biotherapeutics, please visit
51 to 200 staff
Brainbox Solutions, Inc
BRAINBox Solutions™ multi-modality approach is led by the leaders in the industry. It will include blood biomarker panels available on a point of care instrument and standard laboratory systems, as well as neurocognitive testing, to provide objective evidence of injury and prediction of patient recovery.
11 to 50 staff
Cell Culture Company
Cell Culture Company is a biotech organization located in Minneapolis, MN. Headquarters include corporate offices, manufacturing operations, regulated clean room spaces, and a distribution center. C3 offers tools and services to the therapeutic, cell therapy, diagnostic, genomic, animal health, food safety and research industries. C3 team members are experts in aseptic technique, bioreactor manufacturing, cell culture, purification, quality control, analytics and regulatory compliance. C3 has supported 20+ FDA clinical trials and serviced 1,700+ global laboratories. We are a growing biotech company with opportunities for talented individuals who want to support life-saving products.
11 to 50 staff
Cell Microsystems
Cell Microsystems’ transformative platforms for cell engineering, culture, and analysis empower laboratories worldwide to unlock the full potential of their cells, making what was once impossible possible. Fueling progress in research and discovery, their product range includes the CellRaft AIR System, which fosters the growth and isolation of healthy monoclonal colonies; the BioFlux Shear Flow Systems, which replicate in vivo conditions using physiological shear flow; the CERO 3D Cell Culture & Bioreactor for long-term organoid growth and 3D culture expansion; as well as comprehensive lab services and other innovative offerings. Learn more at
11 to 50 staff
Cidara Therapeutics
Cidara Therapeutics is using its proprietary Cloudbreak® platform to develop novel DFCs comprising targeted small molecules or peptides coupled to a proprietary human antibody fragment. Cidara’s lead DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly inhibiting viral proliferation.
11 to 50 staff
Conception Nurseries
Conception is bringing tissue culture technology, a crucial component of industrial scale agriculture, to the cannabis industry. Via tissue culture micropropagation, Conception produces plantlets that are free of diseases and have exceptional vigor, at a cost-per-plant below producers' in-house costs.
51 to 200 staff
Cytomx Therapeutics
CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with our novel Probody® therapeutic platform. We have a broad pipeline comprised of five clinical-stage programs, with even more in development. Our commitment to transforming lives with safer, more effective therapies is driven by our curiosity and passion for innovation, and our belief that by acting with integrity in an honest, respectful, ethical manner, we have the power to change lives. Our workplace embodies collaboration, open communication, celebrating our successes and holding each other to the highest possible standards. CytomX embraces diversity and seeks to enhance and maintain our culture of equity and inclusion which encourages individuals to be themselves, feel involved, respected and connected. We at CytomX believe that we benefit from each other’s ideas and experiences. We accept our differences and learn from one another, improve together, and embrace change to achieve our corporate and individual objectives. This belief applies to how we work together at CytomX, how we work with others outside CytomX, how we represent CytomX in our communities, and how we endeavor to bring our scientific innovations to a diverse patient population. CytomX acknowledges the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. CytomX is an equal opportunity employer and does not discriminate against any individual or potential candidate because of race, color, religion, sex, national origin, sexual preference or any other legally protected category. CytomX is located in South San Francisco, California, the birthplace of biotechnology. Learn more about us and how we are advancing science to treat cancer differently at
51 to 200 staff
